Immunolight, LLC Receives 200th Worldwide Patent
Immunolight, LLC, a clinical stage biopharmaceutical firm leading the way in advancing technologies to transform cancer treatment, announced today it has been granted its 200th worldwide and 75th US patent in a wide-ranging patent portfolio.
Crain’s Detroit Business News Names Immunolight LLC Most Innovative Company of 2016
Immunolight LLC, a biomedical firm leading the way in technologies that transform energy sources such as low dose X-ray and convert them into energy that is capable of activating a natural compound called psoralen when exposed to UV light, has been named Crain’s Detroit Business News most innovative company for 2016.